{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T10:19:32Z","timestamp":1770891572516,"version":"3.50.1"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,1,6]],"date-time":"2021-01-06T00:00:00Z","timestamp":1609891200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,1,6]],"date-time":"2021-01-06T00:00:00Z","timestamp":1609891200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["Ricerca Corrente"],"award-info":[{"award-number":["Ricerca Corrente"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["COVID-2020-12371817"],"award-info":[{"award-number":["COVID-2020-12371817"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["COVID-2020-12371675"],"award-info":[{"award-number":["COVID-2020-12371675"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Thrombosis J"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>A considerable number of SARS-CoV-2 infected individuals could be asymptomatic and don\u2019t need medical treatment. The clinical spectrum of SARS-CoV-2 infection ranges from asymptomatic cases, medium-intensity forms with mild to moderate symptoms, to severe ones with bilateral pneumonia and respiratory distress. In cases with severe presentation of SARS-CoV-2 infection, the induction of hypercoagulability is one of the pathophysiological mechanism that can contribute to death.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>Here, we reported autoptic evidences of thrombotic pulmonary arterial fatal lesions in an asymptomatic COVID-19 patient, after swab negativization. Whole body complete post-mortem examination was performed, showing the presence of a large thrombus occluding the main pulmonary artery that was the cause of death. Histopathological analysis showed heterogeneous pattern of pathological changes in the lung tissue with numerous vascular thrombi, inflammatory cardiomyopathy and other histopathological modifications in kidneys, spleen and liver.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>This study provides evidences that also asymptomatic patients may be at risk to develop thrombotic complications. An appropriate diagnostic screening for thrombotic complications and the early treatment recommendations of antithrombotic drugs could represent an important topic even in asymptomatic individuals.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12959-020-00255-6","type":"journal-article","created":{"date-parts":[[2021,1,6]],"date-time":"2021-01-06T08:04:01Z","timestamp":1609920241000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Fatal pulmonary arterial thrombosis in a COVID-19 patient, with asymptomatic history, occurred after swab negativization"],"prefix":"10.1186","volume":"19","author":[{"given":"Franca","family":"Del Nonno","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniele","family":"Colombo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9209-1207","authenticated-orcid":false,"given":"Roberta","family":"Nardacci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Falasca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,1,6]]},"reference":[{"key":"255_CR1","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1093\/infdis\/jiaa578","volume":"222","author":"L Falasca","year":"2020","unstructured":"Falasca L, Nardacci R, Colombo D, et al. Postmortem findings in Italian patients with COVID-19: a descriptive full autopsy study of cases with and without comorbidities. J Infect Dis. 2020;222:1807\u201315.","journal-title":"J Infect Dis"},{"key":"255_CR2","first-page":"1","volume":"7","author":"H Asakura","year":"2020","unstructured":"Asakura H, Ogawa H. COVID-19-associated coagulopathy and disseminated intravascular coagulation. Int J Hematol. 2020;7:1\u201313.","journal-title":"Int J Hematol"},{"key":"255_CR3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc2007575","volume":"382","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Xiao M, Zhang S, Xia P, et al. Coagulopathy and Antiphospholipid antibodies in patients with Covid-19. N Engl J Med. 2020;382:e38.","journal-title":"N Engl J Med"},{"key":"255_CR4","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1007\/s11886-020-01327-9","volume":"22","author":"MR Aryal","year":"2020","unstructured":"Aryal MR, Gosain R, Donato A, Pathak R, Bhatt VR, Katel A, Kouides P. Venous thromboembolism in COVID-19: towards an ideal approach to Thromboprophylaxis, screening, and treatment. Curr Cardiol Rep. 2020;22:52.","journal-title":"Curr Cardiol Rep"},{"key":"255_CR5","doi-asserted-by":"publisher","unstructured":"Qiu J. Covert coronavirus infections could be seeding new outbreaks. Nature. 2020. https:\/\/doi.org\/10.1038\/d41586-020-00822-x Epub 2020\/03\/24.","DOI":"10.1038\/d41586-020-00822-x"},{"key":"255_CR6","doi-asserted-by":"crossref","unstructured":"Kong W, Wang Y, Hu J, Chughtai A, Pu H. Clinical Research Collaborative Group of Sichuan Provincial People's Hospital. Comparison of clinical and epidemiological characteristics of asymptomatic and symptomatic SARS-CoV-2 infection: A multi-center study in Sichuan Province, China. Travel Med Infect Dis. 2020;37:101754.","DOI":"10.1016\/j.tmaid.2020.101754"},{"key":"255_CR7","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1111\/jth.14768","volume":"18","author":"N Tang","year":"2020","unstructured":"Tang N, Li D, Wang X, Sun Z. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost. 2020;18:844\u20137.","journal-title":"J Thromb Haemost"},{"key":"255_CR8","doi-asserted-by":"publisher","unstructured":"Mahmoud B. Malas, Isaac N. Naazie, Nadin Elsayed, Asma Mathlouthi, Rebecca Marmor, Bryan Clary, Thromboembolism risk of COVID-19 is high and associated with a higher risk of mortality: A systematic review and meta-analysis, EClinicalMedicine, 2020;https:\/\/doi.org\/10.1016\/j.eclinm.2020.100639.","DOI":"10.1016\/j.eclinm.2020.100639"},{"key":"255_CR9","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1055\/s-0040-1710019","volume":"120","author":"Z Zhai","year":"2020","unstructured":"Zhai Z, Li C, Chen Y, Gerotziafas G, Zhang Z, Wan J, Liu P, Elalamy I, Wang C. Prevention Treatment of VTE Associated with COVID-19 Infection Consensus Statement Group. Prevention and Treatment of Venous Thromboembolism Associated with Coronavirus Disease 2019 Infection: A Consensus Statement before Guidelines. Thromb Haemost. 2020;120:937\u201348.","journal-title":"Thromb Haemost"},{"key":"255_CR10","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1111\/jth.14830","volume":"18","author":"S Cui","year":"2020","unstructured":"Cui S, Chen S, Li X, Liu S, Wang F. Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia. J Thromb Haemost. 2020;18:1421\u20134.","journal-title":"J Thromb Haemost"},{"key":"255_CR11","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1111\/jth.14869","volume":"18","author":"JF Llitjos","year":"2020","unstructured":"Llitjos JF, Leclerc M, Chochois C, Monsallier JM, Ramakers M, Auvray M, Merouani K. High incidence of venous thromboembolic events in anticoagulated severe COVID-19 patients J. Thromb Haemost. 2020;18:1743\u20136.","journal-title":"Thromb Haemost"},{"key":"255_CR12","doi-asserted-by":"publisher","first-page":"2698","DOI":"10.1161\/01.CIR.0000131660.51520.9A","volume":"109","author":"M Levi","year":"2004","unstructured":"Levi M, van der Poll T, Buller HR. Bidirectional relation between inflammation and coagulation. Circulation. 2004;109:2698\u2013704.","journal-title":"Circulation."},{"key":"255_CR13","doi-asserted-by":"publisher","first-page":"268","DOI":"10.7326\/M20-2003","volume":"173","author":"D Wichmann","year":"2020","unstructured":"Wichmann D, Sperhake JP, L\u00fctgehetmann M, et al. Autopsy Findings and Venous Thromboembolism in Patients With COVID-19: A Prospective Cohort Study. Ann Intern Med. 2020;173:268\u201377.","journal-title":"Ann Intern Med"},{"key":"255_CR14","doi-asserted-by":"publisher","first-page":"350","DOI":"10.7326\/M20-2566","volume":"173","author":"SF Lax","year":"2020","unstructured":"Lax SF, Skok K, Zechner P, Kessler HH, et al. Pulmonary Arterial Thrombosis in COVID-19 With Fatal Outcome : Results From a Prospective, Single-Center, Clinicopathologic Case Series. Ann Intern Med. 2020;173:350\u201361.","journal-title":"Ann Intern Med"},{"key":"255_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1017\/S1049023X20001466","volume":"17","author":"M Goldenfeld","year":"2020","unstructured":"Goldenfeld M, Nir-Paz R, Segal G, Bar-On E, et al. Characteristics of clinically asymptomatic patients with SARS-CoV-2 infections, Case Series. Prehosp Disaster Med. 2020;17:1\u20134.","journal-title":"Prehosp Disaster Med"},{"key":"255_CR16","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1161\/CIRCULATIONAHA.120.047549","volume":"142","author":"PP Liu","year":"2020","unstructured":"Liu PP, Blet A, Smyth D, Li H. The science underlying COVID-19: implications for the cardiovascular system. Circulation. 2020;142:68\u201378.","journal-title":"Circulation."},{"key":"255_CR17","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1111\/jth.14810","volume":"18","author":"J Thachil","year":"2020","unstructured":"Thachil J, Tang N, Gando S, Falanga A, Cattaneo M, Levi M, Clark C, Iba T. ISTH interim guidance on recognition and management of coagulopathy in COVID-19. J Thromb Haemost. 2020;18:1023\u20136.","journal-title":"J Thromb Haemost"},{"key":"255_CR18","doi-asserted-by":"crossref","unstructured":"Hardy M, Lecompte T, Douxfils J, et al. Management of the thrombotic risk associated with COVID-19: guidance for the hemostasis laboratory. Thromb J. 2020;18:17.","DOI":"10.1186\/s12959-020-00230-1"}],"container-title":["Thrombosis Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12959-020-00255-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12959-020-00255-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12959-020-00255-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,6]],"date-time":"2021-01-06T08:18:02Z","timestamp":1609921082000},"score":1,"resource":{"primary":{"URL":"https:\/\/thrombosisjournal.biomedcentral.com\/articles\/10.1186\/s12959-020-00255-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,6]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["255"],"URL":"https:\/\/doi.org\/10.1186\/s12959-020-00255-6","relation":{},"ISSN":["1477-9560"],"issn-type":[{"value":"1477-9560","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,6]]},"assertion":[{"value":"22 September 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the local ethics committee (Ethics Committee approval number 9\/2020).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable as no patient identifiable data was included, and the patient had expired.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1"}}